Related Experiment Videos
Hyperpigmented small spots induced by long-term PUVA therapy. A clinical, light and electron microscopic study
Summary
Photochemotherapy (PUVA) can cause persistent hyperpigmented spots due to increased melanocyte activity and pigment transfer. These side effects, involving melanocytic damage, may persist long after treatment cessation.
Area of Science:
- Dermatology
- Photobiology
- Histopathology
Background:
- Photochemotherapy (PUVA) is a common treatment for various skin conditions.
- PUVA therapy involves exposure to ultraviolet A (UVA) light in conjunction with a photosensitizing agent (psoralen).
- Adverse skin reactions can occur following PUVA treatment.
Purpose of the Study:
- To investigate the cause of persistent disseminated hyperpigmented small spots observed in patients treated with PUVA.
- To analyze the histological, histochemical, and ultrastructural changes associated with these PUVA-induced spots.
- To compare these findings with other light-induced hyperpigmentations.
Main Methods:
- Histological, histochemical, and electron microscopy studies were conducted on skin biopsies from affected patients.
- Analysis of melanocyte count, activity, and pigment transfer.
- Comparison of lesional skin with interlesional skin and other light-dependent hyperpigmentations.
Main Results:
- A significant increase in melanocytes and hyperactivity of melanocytes were observed in the hyperpigmented spots.
- Increased pigment transfer to dermis and keratinocytes was noted.
- Evidence of melanocytic damage, including binucleated cells, was present, with some changes persisting for at least 7 months post-treatment.
Conclusions:
- PUVA therapy can induce persistent hyperpigmented spots characterized by melanocytic hyperactivity and damage.
- The observed alterations suggest a complex response to PUVA, involving both epidermal and dermal components.
- These findings contribute to understanding the long-term dermatological side effects of photochemotherapy.